Author
Güldane Cengiz Seval
Also Known As
Ayse Kalkanci, G. Cengiz Seval, G. Seval, G.C. Seval, G.Cengiz Seval, GC Seval, Guldane C. Seval, Guldane Cengiz Seval, Guldane Cengiz-Seval, Guldane Cengiz‐Seval
175
Publications
1.3K
Citations
16
H-Index
19
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 3 | 3 | 54 |
2 | Public Health | 2 | 2 | 75 |
3 | Blood Transplantation | 2 | 2 | 75 |
4 | Immunology | 1 | 1 | 18 |
5 | Obstetrics | 1 | 1 | 25 |
Güldane Cengiz Seval
×
18
Publications
708
Citations
13
H-Index
| Year | Citations | |
|---|---|---|
2021 | 312 | |
2019 | 86 | |
2013 | 50 | |
2023 | 36 | |
2024 | 29 | |
2013 | 25 | |
2023 | 25 | |
2022 | 18 | |
Phase 3 Study of Teclistamab (Tec) in Combination with Lenalidomide (Len) and Tec Alone Versus Len Alone in Newly Diagnosed Multiple Myeloma (NDMM) As Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT): Safety Run-in (SRI) Results from the Majestec-4/EMN30 Trial | 2024 | 18 |
2020 | 15 |
Page 1
Page 1